Seoul National University is a national research university located in Seoul, South Korea. It is one of the flagship Korean national universities. Founded in 1946, Seoul National University is considered the most prestigious university in South Korea.

During the past decade, Seoul National University conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul National University" #1 sponsor was "Seoul National University Hospital" with 9 trials, followed by "Korea Otsuka Pharmaceutical Co., Ltd." with 3 trials sponsored, "Agenus Inc." with 1 trials sponsored, "Amorepacific Corporation" with 1 trials sponsored and "Chung-Ang University Hosptial, Chung-Ang University College of Medicine" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul National University" #1 collaborator was "Asan Medical Center" with 2 trials as a collaborator, "Korea University Anam Hospital" with 2 trials as a collaborator, "National Clinical Research Coordination Center, Seoul, Korea" with 2 trials as a collaborator, "National Evidence-Based Healthcare Collaborating Agency" with 2 trials as a collaborator and "National Institute of Health, Korea" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Seoul National University" are "Advanced Cancer" (2 trials), "Asthma" (1 trials), "Breast Cancer" (1 trials), "COPD" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Seoul National University" in a lesser frequency.

Most popular intervention types in "Seoul National University" are "Drug" (11 trials), "Other" (4 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "A book about chronic disease" (1 trials), "AGEN1884" (1 trials), "AGEN2034" (1 trials), "CDP870 200mg" (1 trials) and "Cervical epidural steroid injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University" are 24 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Seoul National University". 1 are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Seoul National University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University, 5 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".

Seoul National University has several departments that took part in Clinical trials: "Department of Dermatology, Seoul National University College of Medicine" - 6 trials, "Department of Surgery, Seoul National University College of Medicine" - 3 trials, "Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine" - 2 trials, "Seoul National University College of Medicine - Liver Research Institute" - 2 trials, "Department of Preventive Medicine, College of Medicine, Seoul National University" - 2 trials